VanDeusen, J. B., Osada, T., Morse, M., Clary, B. M., Lyerly, H. K., Nevins, J. R., … Hsu, S. D. (2010). Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations. In Journal of Clinical Oncology (Vol. 28, pp. e14064–e14064). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.e14064

VanDeusen, J. B., T. Osada, M. Morse, B. M. Clary, H. K. Lyerly, J. R. Nevins, T. M. Clay, P. G. Febbo, and S. D. Hsu. “Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations.” In Journal of Clinical Oncology, 28:e14064–e14064. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.e14064.

VanDeusen JB, Osada T, Morse M, Clary BM, Lyerly HK, Nevins JR, et al. Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. e14064–e14064.

VanDeusen, J. B., et al. “Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. e14064–e14064. Crossref, doi:10.1200/jco.2010.28.15_suppl.e14064.

VanDeusen JB, Osada T, Morse M, Clary BM, Lyerly HK, Nevins JR, Clay TM, Febbo PG, Hsu SD. Use of gene expression signatures to predict in vivo sensitivity of human metastatic colorectal cancer to chemotherapy and to identify novel drug combinations. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. e14064–e14064.